Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. (Q51370927)

4 April 2018

title

Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. (English)

1 reference

4 April 2018

0 references

0 references

Augusto Tinoco

1

1 reference

4 April 2018

Luciana El-Kadre

2

1 reference

4 April 2018

Livia Aquiar

3

1 reference

4 April 2018

Renam Tinoco

4

1 reference

4 April 2018

Paulo Savassi-Rocha

5

1 reference

4 April 2018

publication date

1 October 2011

1 reference

4 April 2018

published in

World Journal of Surgery

1 reference

4 April 2018

volume

35

1 reference

4 April 2018

issue

10

1 reference

4 April 2018

page(s)

2238-2244

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00268-011-1188-2

exact match

0 references

cites work

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Incretins, insulin secretion and Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Peripheral neuropathy and severe malnutrition following duodenal switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Need for parenteral iron therapy after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Nutrition and gastrointestinal complications of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Ileal transposition provides insight into the effectiveness of gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Executive summary: Standards of medical care in diabetes--2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Bariatric surgery worldwide 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Bariatric surgery training in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Effect of sleeve gastrectomy on patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Impact on dyslipidemia of the laparoscopic ileal interposition associated to sleeve gastrectomy in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Ileal interposition with sleeve gastrectomy for control of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Three hundred laparoscopic Roux-en-Y gastric bypasses: managing the learning curve in higher risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Laparoscopic Roux-en-Y gastric bypass: initial 2-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): A new surgical procedure as effective as gastric bypass for weight control in a porcine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1188-2

How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number

21 January 2018

1 reference

12 December 2020

Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass

1 reference

12 December 2020

Energy balance and regulation of body weight after intestinal bypass surgery in rats

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

The kinetics of insulin in man. I. General aspects

1 reference

12 December 2020

Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss

1 reference

12 December 2020

Regulation of ghrelin in physiologic and pathophysiologic states.

1 reference

12 December 2020

Access to bariatric surgery and patients with diabetes

1 reference

12 December 2020

The effects of ileal transposition on food intake and body weight loss in VMH-obese rats

1 reference

12 December 2020

Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes.

1 reference

12 December 2020

10.1007/S00268-011-1188-2

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

21744166

1 reference

4 April 2018